Digital Programme

This year’s digital AMR Conference was an international forum to discuss AMR in the context of COVID-19 and beyond.

Each day covered a focus topic with LIVE sessions and high-level panels:
Lessons learned from COVID-19 | Business Models & Policy Incentives | Global Markets | Financing & Investing | Outlook & Policy Roadmap

Registered participants have access to on-demand versions of all sessions.

Overall theme of the day: Lessons learned from COVID-19

09:45–10:45 CET

Additional programme:
BEAM Alliance meet-up (for members only)

11:00–12:30 CET

Additional programme:
Expert campus | Top 10 mistakes in antibacterial development

This content has been restricted to logged in users only. Please login to view this content.

Jointly organised by Novo REPAIR Impact Fund, CARB-X, GARDP and Wellcome Trust

                      

Moderator:

  • Ursula Theuretzbacher – Founder, CEFAIA

Speakers:

  • Peter Warn – SVP, Anti-infective Discovery, Evotec
  • Richard Knight – Director & Co–founder, ApconiX
  • Aleksander Danilovski – CSO & Senior Vice President Global R&D and Regulatory Affairs, Xelia
13:30–15:00 CET

Opening Session | Infectious diseases in the global spotlight: Why COVID-19 has an impact on AMR

This content has been restricted to logged in users only. Please login to view this content.

Moderator: 

  • Deborah A O’Neil – CEO, NovaBiotics Ltd & Board Member, BEAM Alliance

Speakers:

  • Manica Balasegaram – Executive Director, GARDP
  • Rafael Cantón – Head of the Clinical Microbiology Department, University Hospital Ramón y Cajal Madrid
  • Sergio Carmona – Chief Access Officer, FIND

Further reading tips:

15:15–16:15 CET

Diagnostics | Why diagnostics are a gamechanger to control a pandemic and what this means for combatting AMR

This content has been restricted to logged in users only. Please login to view this content.

Moderator and speaker:

  • Sergio Carmona, Chief Access Officer, FIND

Speakers:

  • Rosanna Peeling, Professor and Chair, Diagnostics Research & Director, International Diagnostics Centre, London School of Hygiene & Tropical Medicine
  • Claudia Denkinger, Head of Division of Tropical Medicine, University Hospital Heidelberg
  • Stefanie Deinhardt-Emmer, a clinical expert from University Clinic of Jena, Germany
  • Joe Fitchett, Medical Director, Mologic

Further reading tips:

16:30–18:00 CET

One Health | Why it is more important than ever to think cross-sectoral

This content has been restricted to logged in users only. Please login to view this content.

Moderator and Speaker:

  • Ghada Zoubiane – Head of Partnerships and Stakeholder Engagement, ICARS

Speakers:

  • Viviana Muñoz-Tellez – Coordinator, Development, Innovation and Intellectual Property Programme (DIIP), South-Centre
  • Mark Holmes, Professor in Microbial Genomics & Veterinary Science, University of Cambridge
  • Elmar Nimmesgern – Secretariat Lead, Global AMR R&D Hub
  • Timo Minssen – Founder and Managing Director, Center for Advanced Studies in Biomedical Innovation Law (CeBIL)

Further reading tips:

ALL DAY Virtual 1:1 Partnering Meetings – LOGIN HERE

Overall theme of the day: Business Models & Policy Incentives

09:30 – 11:00 CET

Expert campus | How to accelerate AMR drug discovery & development

This content has been restricted to logged in users only. Please login to view this content.

Moderation:

  • Isabelle Bekeredjian-Ding – Head of Department, Paul-Ehrlich Institut

Speakers:

  • Claus Stie Kallesøe – CEO & Co-founder, grit42
  • Dirk Bumann – Professor for Infection Biology, The Center for Molecular Life Sciences, University of Basel
  • Dave Madge – Vice President, Research Service Division, WuXi AppTec
  • Cuong Vuong, Director Bacteriology, AiCuris

Further reading tips:

11:15–12:15 CET

ENABLE: A public-private partnership for antibiotic development

This content has been restricted to logged in users only. Please login to view this content.

Speakers:

  • Anders Karlén – ENABLE Coordinator, Uppsala University
  • Jürgen Brem – Project Leader OU-ENABLE, Oxford University
  • Francois Moreau – Scientific Director, Mutabilis
  • Sven Hobbie – CEO & Co-founder, Juvabis

Further reading tips:

13:30–15:00 CET

Business models | The AMR company of the future – Which route to success

This content has been restricted to logged in users only. Please login to view this content.

Sponsored by:

Moderator: 

  • Erin Duffy – Chief of Research & Development, CARB-X

Speakers:

  • Jonathan Butcher – Head of Business Development, BioVersys AG
  • Cherif Bousselham – Senior Vice President, Head of Sales, EMEA, Accelerate Diagnostics Inc.
  • Jean-Pierre Paccaud – Director of Business Development and Corporate Strategy, GARDP
  • Kenneth Bradley – Global Head, Infectious Disease Discovery, Roche

Further reading tips:

15:15–16:15 CET

Business models in AMR | How to develop strategic decisions in a challenging and global AMR market

This content has been restricted to logged in users only. Please login to view this content.

Sponsored by:

Moderator: 

Speakers:

  • Peter Beyer – Senior Advisor Department of Essential Medicines & Health Products, WHO
  • Erin Duffy – Chief of Research & Development, CARB-X
  • Holger Zimmermann – CEO, AiCuris

Further reading tips:

16:30–17:45 CET

AMR pull incentives | Will COVID-19 speed up or slow down implementation?

This content has been restricted to logged in users only. Please login to view this content.

Moderator:

  • Kathy Talkington, Director Health Programs, Pew Charitable Trust

Speakers:

  • Suzanne Edwards – Programme Officer/Economist, Global AMR R&D Hub
  • Kevin Outterson – Professor of Law & Executive Director, CARB-X
  • Colm Leonard – Clinical Advisor/Consultant, NICE
  • Daniel Berman – Lead of the Global Health Team, Longitude Prize / Nesta

Further reading tips:

17:45–18:45 CET

Diagnostics | Novel solutions to solve the reimbursement challenge

This content has been restricted to logged in users only. Please login to view this content.

Moderator:

  • Till Bachmann – Deputy Head of Infection Medicine and Personal chair of Molecular Diagnostics and Infection, University of Edinburgh

Speakers:

  • Colm Leonard – Clinical Advisor/Consultant, NICE
  • Philippe Cleuziat – Innovation Program Senior Director, bioMérieux, VALUE-Dx
  • Daniel Berman – Lead of the Global Health Team, Longitude Prize / Nesta
  • Cecilia Ferreyra, Head of AMR Programme, FIND

Further reading tips:

19:00–20:00 CET

Expert Campus | Diagnostics in clinical trial settings

This content has been restricted to logged in users only. Please login to view this content.

Supported by:

Moderator:

  • Daniel Berman – Lead of the Global Health Team, Longitude Prize / Nesta

Speakers:

  • Kwangmin Son – Co-founder & CEO, Phast Corp.
  • Michael Lobritz – Translational Project Leader, Roche
  • Laurenz Kellenberger, CSO, Basilea

Further reading tips:

ALL DAY Virtual 1:1 Partnering Meetings – LOGIN HERE

Overall theme of the day: Global Markets

09:15–10:45 CET

Expert campus | Focus on tuberculosis

Supported by:

This content has been restricted to logged in users only. Please login to view this content.

Moderation & Introduction:

  • Santiago Ramón-García, Research & Development Agency of Aragon (ARAID) Foundation & Mycobacterial Genetics Group, Dept. of Microbiology, University of Zaragoza
  • Ruben Hartkoorn – Institut Pasteur de Lille, INSERM

Speakers:

  • Michel Pieren – Project Manager, BioVersys AG, CH
  • Florian Kloss – Head, Hans Knöll Institute (HKI), GER
  •  Michael Hoelscher – Network Coordinator, Ludwig-Maximilians-University Munich (LMU), GER

Further reading tips:

11:00–12:30 CET

Expert campus | Diagnostics in Drug-resistant TB

This content has been restricted to logged in users only. Please login to view this content.

Moderation: 

  • Anita Suresh – Head of Sequencing, FIND

Speakers:

  • Courtney Maus – Scientific Director Life Sciences, BD
  • Sebastian Dümcke – CEO, Clemedi AG
  • Dessislava Tarlton, Programme Management Officer, molecular diagnostics and cervical cancer, Unitaid

Further reading tips:

13:30–15:00 CET

Global markets | Why we need to think global to tackle AMR

This content has been restricted to logged in users only. Please login to view this content.

Moderator:

  • Marc Lemonnier – Founding CEO, Antabio SAS

Speakers:

  • Heiman Wertheim – Head of Clinical Microbiology Department, Radboud University Medical Center
  • Anand Anandkumar – CEO, Bugworks
  • Alexandra Cameron – Senior Technical Manager Strategy Team, UNITAID
  • Bruce Altevogt, Vice President and Head External Medical Engagement, Hospital Business Unit, Pfizer

Further reading tips:

15:15–17:00 CET

Clinical trials | Why global networks are crucial to speed up late stage clinical development

This content has been restricted to logged in users only. Please login to view this content.

Moderator:

  • Ron de Winter – Programme Manager European Projects, UMC Utrecht

Speakers:

  • Seamus O’Brien – R&D Director, GARDP
  • Tim Jinks – Head of Antibiotic Resistance Infections Program, Wellcome Trust
  • Florence Séjourné – CEO, DaVolterra & President, BEAM Alliance
  • Kamini Walia – Head of AMR, ICMR, Government of India

Further reading tips:

17:45–18:30 CET

Regulatory perspective | Current status and the post-COVID outlook for antibiotic clinical trials & approvals

This content has been restricted to logged in users only. Please login to view this content.

Moderator:

  • John Rex, Chief Medical Officer, F2G Ltd.

Speakers:

  • Sumathi Nambiar – Director Division of Anti-Infective Products, Office of Infectious Diseases, FDA
  • Marco Cavalieri – Head of Antiinfectives and Vaccines, Safety&Efficacy Sector, EMA

Further reading tips:

ALL DAY Virtual 1:1 Partnering Meetings – LOGIN HERE

Overall theme of the day: Financing & Investing

09:45–10:45 CET

Start-up campus | Live pitches with jury voting hosted by Novo Repair Impact Fund

This content has been restricted to logged in users only. Please login to view this content.

Congratulations to the winner of our Start-up up pitch session, Neciah Dorh, CEO & Co-Founder of FluoretiQ.

Jury Members:

  • Peter Jackson, AMR Centre (Moderator)
  • Camilla Petrycer Hansen, Novo Holding 
  • Erin Duffy, Chief of R&D, CARB-X
  • Holger Zimmermann, CEO, AiCuris
  • Fiona Marston, Director, CEIDR 

With pitches from:

  • Irene Wütherich , Co-Founder, Spherobiotics
  • Thomas Hesterkamp, Head of Translational Project Management Office, HZI/DZIF & Myxobiotics
  • Miron Tokarski, CEO & Co-Founder, Genomtec
  • Neciah Dorh, CEO & Co-Founder, FluoretiQ

Further reading tips:

11:00–12:00 CET

SME campus (Part I) | Focus on therapeutics

This content has been restricted to logged in users only. Please login to view this content.

Speakers:

  • Marc Gitzinger – CEO and Founder, BioVersys AG
  • Nadine Taudte – Head of Laboratory, Periotrap Pharmaceuticals
  • Samareh Azeredo da Silveira Lajaunias – Founding Partner and General Manager, Combioxin SA
  • Holger Zimmermann,  CEO, AiCuris

Further reading tips:

12:00–13:15 CET

SME campus (Part II) | Focus on diagnostics

This content has been restricted to logged in users only. Please login to view this content.

Moderation:

  • Betsy Wonderly Trainor, Alliance Manager, CARB-X

Speakers:

  • Colin Denver – CEO, SpeeDx
  • Peter Haug – CFO & Co-Founder, Head of Business Development & Licensing, Noscendo GmbH
  • Piotr Gastrecki – CTO, Scope Fluidics
  • Rosemarie Preyer – GenID GmbH
  • Doug Kwon, Scientific Co-founder, Day Zero Diagnostics & Associate Professor, Harvard Medical School

Further reading tips:

13:30–15:00 CET

Financing resistance | Why new investors are urgently needed and where they come from

This content has been restricted to logged in users only. Please login to view this content.

Moderator:

  • Peter Beyer – Senior Advisor Department of Essential Medicines & Health Products, WHO

Speakers:

  • Thomas Cueni – Director General, IFPMA
  • James Anderson – Head of Corporate Government Affairs, GSK
  • Silas Holland – Head of External Affairs for the AMR Action Fund &  Director for Global Public Policy MSD
  • Deborah A O’Neil – CEO, NovaBiotics Ltd & Board Member, BEAM Alliance
  • Aleks Engel – Partner, Novo Holdings (Novo Seeds) & Director, REPAIR Impact Fund at Novo Holdings

Further reading tips:

15:15–16:15 CET

Spotlight on UK | Investor Action on AMR

Watch the session recording here 

Sponsored by:

  

Moderator:

  • Louise Norton-Smith, Head of Global Antimicrobial Resistance Strategy & Delivery, UK Department of Health & Social Care

Keynote:

  • Dame Sally Davies – UK Special Envoy on Antimicrobial Resistance & former Chief Medical Officer for England

Speakers for the panel discussion:

  • Maria Lettini, Executive Director, FAIRR Initiative
  • Mara Lilley, Investor Engagement Manager, Access to Medicine Foundation
  • Catherine McCabe, Senior Associate | Analyst | Responsible Investment, BMO Global Asset Management (EMEA)
  • Matt Crossman, Stewardship Director, Rathbone Investment Management

Further reading tips:

16:30–17:30 CET

Behind the scenes | Perspectives from investors, accelerators & incubators

This content has been restricted to logged in users only. Please login to view this content.

Moderator:

  • Erin Duffy – Chief of Research & Development, CARB-X

Speakers:

  • Aleks Engel – Partner, Novo Holdings (Novo Seeds) & Director, REPAIR Impact Fund at Novo Holdings
  • Uzma Choudry – VC Investor at Octopus Ventures
  • Igor Orshanskiy, Associate Director Business Development & Alliance Management, AiCuris
  • Graham Somers, IMI portfolio Director, GSK

Further reading tips:

17:45–18:30 CET

Expert campus | Perspective on late stage clinical development

This content has been restricted to logged in users only. Please login to view this content.

Moderation:

  • Fiona Marston, Director, Centre of Excellence in Infectious Diseases (CEIDR)

    Speakers:
  • Sarah Paulin, Technical Officer on Antimicrobial Resistance (AMR), World Health Organization (WHO)
  • Laurenz Kellenberger – CSO, Basilea
  • Patrick Velicitat – CMO, Allecra

Further reading tips:

ALL DAY Virtual 1:1 Partnering Meetings – LOGIN HERE

Overall theme of the day: Outlook & Roadmap

09:30–10:45 CET

Expert campus | Animal Health

This content has been restricted to logged in users only. Please login to view this content.

Speakers:

  • Klaus Hellmann – Klifovet AG
  • Harald Peter – Fraunhofer IZI-BB
  • Christophe Chatain – Executive assistant & Sales Manager, Vetophage
  • Mai Huong Chatain-Ly -President & Scientific Director, Vetophage
  • Hosny El-Adawy – Institute of Bacterial Infections and Zoonoses, Friedrich-Loeffler-Institut (FLI)

Further reading tips:

11:00–12:30 CET

Expert campus | Novel approaches in Drug development

This content has been restricted to logged in users only. Please login to view this content.

Moderator:

  • Till  Schäberle – Professor, Department of Insect Biotechnology at University of Gießen &  Fraunhofer Institute for Molecular Biology and Applied Ecology (IME)

Speakers:

  • Albina Poljak – Director Business Development, PhagoMed Biopharma GmbH
  • Timothy Schulz-Utermoehl – Co-founder & Director, Pedanius Therapeutics
  • Niamh Máire Mohan – Pre-Clinical Technologist, Nuritas limited
  • Till  Schäberle – Professor, Department of Insect Biotechnology at University of Gießen &  Fraunhofer Institute for Molecular Biology and Applied Ecology (IME)
  • Cesar de la Fuente – Machine Biology Group, University of Pennsylvania

Further reading tips:

13:30–15:00 CET

Closing session The future of AMR: How a new post-COVID-19 policy roadmap could look like

Watch the session recording here 

Moderator:

Speakers:

  • Renu Swarup –  Secretary, Head of Department of Biotechnology (DBT), Ministry of Science and Technology,  Government of India
  • Dame Sally Davies – UK Special Envoy on Antimicrobial Resistance & former Chief Medical Officer for England
  • Tiemo Woelken – MEP S&D German, vice-chair of European Parliament MEP Interest Group on AMR
  • Catharina Boehme – CEO, FIND
  • Evan Loh, MD, CEO, Paratek & Chair, Antimicrobials Working Group, US

Further reading tips:

ALL DAY Virtual 1:1 Partnering Meetings – LOGIN HERE

BEAM Alliance programme committee

Marc Gitzinger

CEO, BioVersys AG, CH & Vice President Board, BEAM Alliance

Marc Lemonnier

Founding CEO, Antabio SAS

Deborah O’Neil

CEO, NovaBiotics Ltd & Board Member, BEAM Alliance